**Ticker: VAXFAB | Exchange: BSE | Industry: Textiles & Multi-Sector Trading** Vaxfab Enterprises Limited (formerly **Ellora Trading Limited**) is an Indian public entity currently undergoing a radical structural transformation. Historically a textile trading firm, the company is aggressively pivoting toward a diversified conglomerate model, backed by significant capital raising and a series of strategic acquisitions. --- ### Corporate Evolution & Strategic Pivot Vaxfab is transitioning from a niche textile player into a multi-commodity and services platform. In **May 2025**, the company formally amended its **Memorandum of Association (MoA)** to authorize entry into high-growth sectors beyond its traditional scope. **New Business Verticals:** * **Agri-Inputs & Commodities:** Manufacturing and trading of fertilizers, pesticides, livestock feed, and essential grains (pulses, oilseeds). * **Precious Metals:** Trading in **Gold bullion**, bars, coins, silver, and platinum, alongside jewelry manufacturing. * **Travel & Logistics:** Comprehensive tour operations (air, rail, ship) and transport services (taxis, buses, trucks). * **Consumer Goods:** Distribution of domestic electrical and audio-visual appliances (ACs, refrigerators, etc.). * **General Trading:** Acting as a broker, C&F agent, and export house for diverse merchandise. To support this shift, the company relocated its registered office to **Surat, Gujarat** in **2024**, positioning itself within India’s primary textile and trading hub to enhance operational efficiency. --- ### Financial Performance & Capital Structure The company’s financial trajectory has been volatile, characterized by a period of explosive revenue growth followed by a recent downturn into net losses. **Three-Year Financial Summary:** | Particulars (₹ in Lakhs) | FY 2023-24 | FY 2022-23 | FY 2021-22 | | :--- | :---: | :---: | :---: | | **Total Revenue** | **928.60** | **1,675.29** | **37.32** | | **Total Expenses** | **912.37** | **1,630.27** | **36.99** | | **Profit Before Tax (PBT)** | **(414.54)** | **45.02** | **0.33** | | **Profit After Tax (PAT)** | **(353.29)** | **33.44** | **0.25** | **Capital Infusion & Fundraising (2025-2026):** To fund its expansion, the Board has significantly increased the company's financial headroom: * **Authorised Share Capital:** Increased from **₹9.30 Crore** to **₹35.00 Crore**. * **Borrowing Limit:** Set at **₹100.00 Crore** under Section 180(1)(c). * **Preferential Issue:** In **September 2025**, the Board approved the issuance of **2,54,94,763 fully convertible warrants** at **₹21.02** per warrant (including a **₹11.02 premium**), totaling approximately **₹53.59 Crore**. * **Warrant Conversion:** As of **April 2026**, the company has begun converting these into equity, recently allotting **12,62,229 equity shares**. --- ### Inorganic Growth & Subsidiary Portfolio Vaxfab is utilizing an acquisition-led strategy to quickly establish a presence in its new target markets. | Target Entity | Stake | Primary Business Line | Strategic Role | | :--- | :---: | :--- | :--- | | **Eklingji Tradelink Pvt Ltd** | **100%** | Paper, Fabrics, & Textiles | Target Turnover: **₹11.31 Cr** (FY25) | | **Aarsha International Ltd** | **100%** | Travel & Tour Operations | Entry into service/logistics sector | | **Satvat Agro LLP** | **Control** | Paper & Agro-trading | Diversification into industrial trading | The company previously held a **20.51%** stake in **Vaxtex Cotfab Limited**, which ceased to be an associate after **June 30, 2023**. --- ### Operational Outlook & Sectoral Tailwinds Management maintains a **cautiously optimistic** outlook for **FY 2025-26**, targeting a **15% increase** in productivity and profits. * **Global Expansion:** Strengthening export footprints in **North America** and **Europe**. * **Value-Added Focus:** Shifting production toward higher-margin products to reverse the net loss of **₹3.57 Crore** seen in FY24. * **Macro Drivers:** Leveraging Indian government initiatives such as **PLI** and **MITRA**. The company anticipates national textile exports to reach **US$ 65 billion by FY26**. * **Modernization:** Ongoing investments in **automation**, **digital transformation**, and **ESG compliance**. --- ### Governance Challenges & Audit Qualifications Investors should note significant governance risks identified during recent audits (as of **December 31, 2025**). The auditors issued a **Disclaimer of Opinion** due to several critical factors: * **Management Transition Issues:** Current management reported that historical records were not fully handed over by the **previous management**, leading to a lack of audit evidence. * **Financial Irregularities:** * **Unsecured Loans:** Loans granted and received without interest or formal agreements. * **Documentation Gaps:** Inadequate records for **trade receivables/payables**, **tax compliance**, and **goods inward/outward**. * **Ind AS Non-compliance:** Failure to apply **Expected Credit Loss (ECL)** models (Ind AS 109) or perform **actuarial valuations** for gratuity liabilities (Ind AS 19). * **Statutory Lapses:** Failure to maintain records under the **MSMED Act, 2006**. --- ### Risk Management Framework The company operates a **Corporate Treasury** function to manage market exposures: * **Currency & Interest Risk:** Uses derivative instruments for hedging transactions within a **12-month period**; speculative trading is strictly prohibited. * **Liquidity Risk:** Managed by the **CFO** to ensure funding for short and long-term requirements. * **External Risks:** Vulnerability to **monsoon uncertainty** (affecting agro-trading), **inflation**, and **geopolitical trade wars**. **Note:** While the financial statements were prepared on a **going concern** basis in early 2026, auditors have explicitly stated that their reports provide no assurance regarding the company's future viability or its ability to discharge liabilities.